Unconventional Developers Creating Vital Products

Biomedical asset development while helping to catalyze the formation of a thriving and sustainable life sciences entrepreneurship ecosystem for local and national markets.

I am an investor interested in early-stage
biotech investing

I am an early career scientist interested in product development

I am a university tech-transfer licensing manager interested in licensing
a technology

What We Do

Fannin primarily in-licenses promising, early-stage therapeutic and medical device technologies from leading academic investigators in the Texas Medical Center and on a national stage.

Fannin develops and de-risks these technologies via preclinical work and engineering up through early clinical trials.

To develop early-stage pharmaceutical and medical device assets that address vital unmet medical needs.

Mission Statement

Robust Pipeline Across Programs

$242m+ Raised Via Grant And Investor Funding

300+ Interns And Fellows Trained

Testimonials

Fannin Team

LEO LINBECK III
M.B.A., M.S.
CHAIRMAN AND FOUNDER

ATUL VARADHACHARY
M.D., PH.D.
MANAGING PARTNER

MARK WORSCHEH
M.B.A. CHIEF
FINANCIAL OFFICER

DEV CHATTERJEE
M.D., M.S., PH.D.
MANAGING DIRECTOR

Partnerships